Aicaigou LogoAicaigou LogoB2B WikiIndustrial Encyclopedia

Urate Transporter

Updated: 2026-07-15

Overview

Urate transporters are specialized proteins embedded in cell membranes, primarily in the kidneys and intestines, that regulate urate movement. They are pivotal in controlling serum uric acid levels, with implications for diseases like gout, cardiovascular disorders, and chronic kidney disease. Research focuses on transporters such as URAT1 (SLC22A12) and GLUT9 (SLC2A9), which are targets for therapeutic interventions. These proteins operate through active transport or exchange mechanisms, often coupled with other ions like lactate or chloride. Their dysfunction can lead to either excessive urate retention (hyperuricemia) or loss (hypouricemia), making them key subjects in nephrology and rheumatology.

Key Features

中性粒细胞趋化蛋白2(NAP-2/CXCL7)ELISA试剂盒上海优科唯生物科技有限公司

Urate transporters exhibit high selectivity for urate ions, though some variants also transport other organic anions. Their expression is tissue-specific, with URAT1 predominantly in renal proximal tubules and GLUT9 in both kidneys and the liver. Structural studies reveal binding pockets that accommodate urate’s molecular shape, enabling targeted drug design. Regulation of these transporters involves hormonal signals (e.g., insulin) and inflammatory cytokines, linking them to metabolic syndromes. Inhibitors like benzbromarone and lesinurad specifically block URAT1, demonstrating their clinical relevance.

商家经验真实案例 · 安全可信
生物碱VS有机磷:谁更“毒”特
本文对比生物碱和有机磷的毒性,分析两者作用机制、常见来源及毒性差异,揭示有机磷急性毒性更强,而生物碱慢性毒性更隐蔽的特点。

Application Areas

In pharmaceuticals, urate transporters are leveraged to develop drugs for gout and hyperuricemia. For instance, URAT1 inhibitors increase urate excretion, while GLUT9 modulators aim to reduce reabsorption. Diagnostic tools targeting these proteins help assess renal handling of uric acid in patients. Beyond medicine, urate transporter research aids in understanding evolutionary adaptations, such as primates’ loss of uricase enzyme function, which increased reliance on these transporters for urate elimination.

Precautions

洁净室专用传递窗定制 密封性强 灭菌物品传输设备上海枫古医药设备有限公司

When studying or targeting urate transporters, consider genetic polymorphisms that affect drug response. For example, certain SLC2A9 variants reduce transporter activity, necessitating personalized dosing. Cross-reactivity in antibody-based assays is another challenge, requiring rigorous validation. In drug development, off-target effects on other transporters (e.g., OAT1/OAT3) must be monitored to avoid nephrotoxicity. Environmental factors like diet and pH also influence transporter efficiency, complicating in vitro-to-in vivo extrapolations.

商家经验真实案例 · 安全可信
小鼠组胺elisa试剂盒
本文介绍小鼠组胺ELISA试剂盒的应用场景、检测原理及操作注意事项,帮助科研人员准确检测生物样本中的组胺含量,为免疫学研究提供可靠工具。

B2B Procurement Guide

Researchers and pharmaceutical firms sourcing urate transporter-related products should prioritize suppliers with documented specificity, such as validated antibodies or knockout cell lines. Reagent purity (e.g., ≥95% for recombinant proteins) and batch consistency are critical for reproducibility. For inhibitors or assay kits, compare IC50 values and selectivity profiles across vendors. Collaborate with specialized manufacturers for custom probes or transgenic models. Budget for secondary validation (e.g., siRNA knockdown) to confirm target engagement.

Related Manufacturers